Thérèse Liechtenstein

Author

University College London

Also Known As

Liechtenstein, T., Michael Hebeisen, T Liechtenstein, T. Liechtenstein, Therese Liechtenstein, Thérèse Liechtenstein

Publications

678

Citations

H-Index

Concepts

All Affiliations

University College London Navarrabiomed Vrije Universiteit Brussel Universidad de Navarra

About

Thérèse Liechtenstein is an author at University College London specializing in cell biology, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	171
2	Cell Biology	3	3	171
3	Immunology	3	3	171
4	Allergy	1	1	48
5	Autoimmune Disease	1	1	82

Thérèse Liechtenstein

Publications

569

Citations

H-Index

Page 1

	Year	Citations
Interference with PD-L1/PD-1 co-stimulation during antigen presentation enhances the multifunctionality of antigen-specific T cells Joeri J. Pen, Brenda De Keersmaecker, Carlo Heirman, Gene Therapy Immunological MemoryAutoimmune DiseaseAdaptive Immune SystemMedicineT-regulatory Cell	2014	82
Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunity Kevin Van der Jeught, Patrick Tjok Joe, Lukasz Bialkowski, Oncotarget	2014	78
<i>Ex vivo</i>generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer Inès Dufait, Julia Katharina Schwarze, Thérèse Liechtenstein, Oncotarget	2015	73
A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice Thérèse Liechtenstein, Noemí Pérez‐Janices, María Gato, Oncotarget	2014	67
A core of kinase-regulated interactomes defines the neoplastic MDSC lineage María Gato, Xabier Martínez de Morentin, Idoia Blanco‐Luquin, Oncotarget	2015	62
Retroviral and Lentiviral Vectors for the Induction of Immunological Tolerance Inès Dufait, Thérèse Liechtenstein, Alessio Lanna, Scientifica ImmunologyImmunotherapyViral PersistenceHuman RetrovirusCancer Vaccines	2012	48
Modulating Co-Stimulation During Antigen Presentation to Enhance Cancer Immunotherapy Thérèse Liechtenstein, Inès Dufait, Alessio Lanna, Immunology Endocrine & Metabolic Agents - Medicinal Chemistry	2012	45
Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using<i>ex vivo</i>myeloid-derived suppressor cells as a readout of therapeutic efficacy Thérèse Liechtenstein, Noemí Pérez‐Janices, Idoia Blanco‐Luquin, OncoImmunology	2014	43
Lentiviral Vectors for Cancer Immunotherapy and Clinical Applications Thérèse Liechtenstein, Noemí Pérez‐Janices, David Escors Cancers Advanced LeukemiaImmunologyImmunotherapeuticsImmune Cell TherapyImmunotherapy	2013	41
Differential involvement of<i>RASSF2</i>hypermethylation in breast cancer subtypes and their prognosis Noemí Pérez‐Janices, Idoia Blanco‐Luquin, Natalia Torrea, Oncotarget	2015	30

Page 1